These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements. Mulinari RA; Zanella MT; Guerra EM; Kohlmann O; Saad CI; Andriollo A; Carvalho JG; Ribeiro AB Braz J Med Biol Res; 1987; 20(1):43-6. PubMed ID: 3690046 [TBL] [Abstract][Full Text] [Related]
29. Complications of clonidine suppression test for pheochromocytoma. Burris JF; D'Angelo LJ N Engl J Med; 1982 Sep; 307(12):756-7. PubMed ID: 7110235 [No Abstract] [Full Text] [Related]
30. [Biological diagnosis of pheochromocytoma: impact of technological improvement]. Peyrin L; Mornex R Ann Biol Clin (Paris); 1993; 51(10-11):835-65. PubMed ID: 8210060 [TBL] [Abstract][Full Text] [Related]
31. Clonidine-suppression test for diagnosis of pheochromocytoma. N Engl J Med; 1982 Jan; 306(1):49-50. PubMed ID: 7053473 [No Abstract] [Full Text] [Related]
32. Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. Macdougall IC; Isles CG; Stewart H; Inglis GC; Finlayson J; Thomson I; Lees KR; McMillan NC; Morley P; Ball SG Am J Med; 1988 Jun; 84(6):993-1000. PubMed ID: 3376984 [TBL] [Abstract][Full Text] [Related]
33. [Metabolism of catecholamines in the clinical biochemistry of hypertension]. Comoy E Ann Med Interne (Paris); 1983; 134(3):233-4. PubMed ID: 6625417 [TBL] [Abstract][Full Text] [Related]
34. Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertension. Bachmann AW; Gordon RD Clin Exp Pharmacol Physiol; 1991 May; 18(5):275-7. PubMed ID: 2065469 [TBL] [Abstract][Full Text] [Related]
35. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. Elliott WJ; Murphy MB Am J Med; 1988 Mar; 84(3 Pt 1):419-24. PubMed ID: 3348244 [TBL] [Abstract][Full Text] [Related]
36. Pheochromocytoma. Current concepts in diagnosis, localization, and management. Bravo EL Prim Care; 1983 Mar; 10(1):75-86. PubMed ID: 6553940 [No Abstract] [Full Text] [Related]
37. Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma. Koshida H; Miyamori I; Soma R; Matsubara T; Okamoto S; Ikeda M; Takeda R J Endocrinol Invest; 1990 Nov; 13(10):807-15. PubMed ID: 2096157 [TBL] [Abstract][Full Text] [Related]
38. [Detection of patients with pheochromocytoma using a cybernetic analysis method of the signs and symptoms of the disease]. Balazovjech I; Mikulecky M; Zanou DF; Zvara V Ann Urol (Paris); 1996; 30(1):7-13. PubMed ID: 8712762 [TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and therapy of endocrine hypertension]. Unger N; Petersenn S; Mann K Med Klin (Munich); 2006 Mar; 101 Suppl 1():170-2. PubMed ID: 16802547 [TBL] [Abstract][Full Text] [Related]
40. Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case. Dupont AG; Vanderniepen P; Gerlo E; Somers G; Vanhaelst L; in't Veld P; Gepts W; Sacre R; Six RO J Endocrinol Invest; 1985 Apr; 8(2):153-6. PubMed ID: 4031382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]